Clinical Trial Update: A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating Dextenza for ocular pain and inflammation after pediatric cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Cataract | Phase 3 | Status: COMPLETED